Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host
Haoran Zhang1, Yong Wang, Jiequn Wu
1Department of Chemical & Biological Engineering, Tufts University, Medford, MA 02155, USA.
Abstract:
Erythromycin A is a potent antibiotic long-recognized as a therapeutic option for bacterial infections. The soil-dwelling bacterium Saccharopolyspora erythraea natively produces erythromycin A from a 55 kb gene cluster composed of three large polyketide synthase genes (each ~10 kb) and 17 additional genes responsible for deoxysugar biosynthesis, macrolide tailoring, and resistance. In this study, the erythromycin A gene cluster was systematically transferred from S. erythraea to E. coli for reconstituted biosynthesis, with titers reaching 10 mg/l. Polyketide biosynthesis was then modified to allow the production of two erythromycin analogs. Success establishes E. coli as a viable option for the heterologous production of erythromycin A and more broadly as a platform for the directed production of erythromycin analogs.
More Related Videos
Related Concept Videos
Production of Antibiotics
Production of Pharmaceuticals
Biosynthesis in Bacteria
Amino Acid Biosynthetic Pathways
Inhibitors of Bacterial Protein Synthesis
Synthetic Biology
Golden rice
Golden rice is a genetically modified...


